Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kala Pharmaceuticals
Pharma
Alcon is adding 2 more arrows to its opthalmic eye drop quiver
The buyout will let Alcon get its hands on Aerie’s marketed glaucoma and ocular hypertension meds Rhopressa and Rocklatan.
Fraiser Kansteiner
Aug 23, 2022 9:24am
Kala buys time by selling eye disease drugs to Alcon for $60M
May 24, 2022 10:35am
AbbVie puts 17-year-old Restasis brand back on TV
Apr 26, 2021 8:35am
Kala beefs up salesforce to roll out dry-eye med Eysuvis
Oct 30, 2020 10:17am
